During the past decade, CPMC Addiction & Pharmacology Research Laboratory (APRL) conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CPMC Addiction & Pharmacology Research Laboratory (APRL)" #1 collaborator was "University of California, San Francisco" with 2 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 1 trials as a collaborator, "National Institutes of Health (NIH)" with 1 trials as a collaborator and "San Francisco General Hospital" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "CPMC Addiction & Pharmacology Research Laboratory (APRL)" are "Healthy" (1 trials), "MDMA Discontinuation Syndrome" (1 trials), "Nasal Congestion" (1 trials) and "Opiate Addiction" (1 trials). Many other conditions were trialed in "CPMC Addiction & Pharmacology Research Laboratory (APRL)" in a lesser frequency.

Most popular intervention types in "CPMC Addiction & Pharmacology Research Laboratory (APRL)" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "3,4-methylenedioxymethamphetamine or Placebo" (1 trials), "6β-Naltrexol escalating doses from 0.05-0.5 mg IV" (1 trials), "MDA" (1 trials), "Placebo" (1 trials) and "d-methamphetamine" (1 trials). Other intervention names were less common.

The vast majority of trials in "CPMC Addiction & Pharmacology Research Laboratory (APRL)" are 4 trials for "All" genders.

Currently, there are NaN active trials in "CPMC Addiction & Pharmacology Research Laboratory (APRL)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in CPMC Addiction & Pharmacology Research Laboratory (APRL), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CPMC Addiction & Pharmacology Research Laboratory (APRL), 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".